Related Experiment Video
Updated: Aug 6, 2026
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
Patient Understanding of Multiple Myeloma and Communication Experiences (PUMMaCE): Results From a UK Survey
Valerie Jenkins1, Rachel Hunter1, Ruth Habibi1
1Sussex Health Outcomes Research & Education in Cancer Brighton & Sussex Medical School University of Sussex Brighton UK.
Introduction:
Multiple myeloma (MM) is a complex haematological cancer. The terminology used can make discussions more challenging. We designed an online patient survey to explore this area.
Methods:
Questions with fixed and free text response options explored understanding of MM and phrases Health Care Professionals (HCPs) and family used that were helpful or not.
Results:
Data from 138 patients revealed that most were satisfied with the HCPs' communication. Many gave examples where information received impacted their understanding, for example, about prognosis, treatment management and support.
Conclusion:
These findings will inform the production of educational materials to improve communication between patients, their families and HCPs.
Trial Registration:
The authors have confirmed clinical trial registration is not needed for this submission.
Related Concept Videos
01:26Methods of Documentation II: POMR
01:21Cancer Survival Analysis
01:27Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...